SAGE THERAPEUTICS INC

CUSIP: 78667J108 Class: Common Stock

FARALLON CAPITAL MANAGEMENT LLC's Holding History (CIK: 0000909661)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 42,800 Value ($000) $390 Avg Close Range
Q1 2025
Shares 42,800 Value ($000) $340 Avg Close Range
Q4 2024
Shares 42,800 Value ($000) $232 Avg Close Range
Q3 2024
Shares 42,800 Value ($000) $309 Avg Close Range
Q2 2024
Shares 42,800 Value ($000) $465 Avg Close Range
Q1 2024
Shares 42,800 Value ($000) $802 Avg Close Range
Q4 2023
Shares 42,800 Value ($000) $927 Avg Close Range
Q3 2023
Shares 42,800 Value ($000) $881 Avg Close Range
Q1 2021
Shares 345,000 Value ($000) $25,823 Avg Close Range
Q4 2020
Shares 1,050,000 Value ($000) $90,836 Avg Close Range
Q3 2020
Shares 1,050,000 Value ($000) $64,176 Avg Close Range
Q2 2020
Shares 850,000 Value ($000) $35,343 Avg Close Range
Q1 2020
Shares 675,000 Value ($000) $19,386 Avg Close Range
Q4 2019
Shares 500,000 Value ($000) $36,095 Avg Close Range
Q3 2019
Shares 372,800 Value ($000) $52,300 Avg Close Range
Q2 2019
Shares 500,000 Value ($000) $91,545 Avg Close Range
Q1 2019
Shares 600,000 Value ($000) $95,430 Avg Close Range
Q4 2018
Shares 400,000 Value ($000) $38,316 Avg Close Range
Q3 2018
Shares 625,000 Value ($000) $88,281 Avg Close Range
Q2 2018
Shares 625,000 Value ($000) $97,831 Avg Close Range
Q1 2018
Shares 445,000 Value ($000) $71,676 Avg Close Range
Q4 2017
Shares 400,000 Value ($000) $65,884 Avg Close Range
Q3 2017
Shares 243,500 Value ($000) $15,170 Avg Close Range
Q2 2017
Shares 100,000 Value ($000) $7,964 Avg Close Range